Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3038

Actual shortage: 231 (8%)
Anticipated shortage: 14 (0%)
Avoided shortage: 9 (0%)
Resolved: 2784 (92%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

31 (12%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-OLMESARTAN/HCTZ 12.5MG 20MG TABLET Anticipated shortage 2024-01-19 2024-01-19 216720
APO-OLMESARTAN/HCTZ 25MG 40MG TABLET Anticipated shortage 2024-01-19 2024-01-19 216717
APO-OLMESARTAN 40MG TABLET Anticipated shortage 2024-01-19 2024-01-19 216714
APO-OLMESARTAN 20MG TABLET Actual shortage 2024-01-19 2024-05-10 216711
APO-QUETIAPINE FUMARATE 300MG TABLET (IMMEDIATE RELEASE) Actual shortage 2024-01-19 2024-02-23 216708
APO-QUETIAPINE FUMARATE 200MG TABLET (IMMEDIATE RELEASE) Actual shortage 2024-01-19 2024-05-08 216705
APO-QUETIAPINE FUMARATE 100MG TABLET (IMMEDIATE RELEASE) Anticipated shortage 2024-01-19 2024-02-06 216702
APO-QUETIAPINE FUMARATE 25MG TABLET (IMMEDIATE RELEASE) Actual shortage 2024-01-19 2024-02-23 216699
APO-QUETIAPINE XR 400MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-01-19 2024-04-19 216696
APO-QUETIAPINE XR 300MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-01-19 2024-04-23 216693
APO-QUETIAPINE XR 200MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-01-19 2024-03-05 216690
APO-QUETIAPINE XR 50MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-01-19 2024-03-22 216687
APO-FINASTERIDE 5MG TABLET Actual shortage 2024-01-19 2024-02-16 216684
APO-AMPHETAMINE XR 5MG CAPSULE (EXTENDED RELEASE) Resolved 2024-01-19 2024-02-23 216681
APO-BROMFENAC 0.07% SOLUTION Resolved 2024-01-19 2024-03-22 216678
APO-TICAGRELOR 90MG TABLET Resolved 2024-01-19 2024-03-29 216675
APO-CEFEPIME 1G POWDER FOR SOLUTION Resolved 2024-01-19 2024-02-09 216672
APO-MOMETASONE 50MCG SPRAY, METERED DOSE Actual shortage 2024-01-19 2024-05-10 216669
APO-FELODIPINE 2.5MG TABLET (EXTENDED-RELEASE) Resolved 2024-01-19 2024-02-09 216662
APO-LEFLUNOMIDE 10MG TABLET Resolved 2024-01-19 2024-02-09 216659

Showing 181 to 200 of 3038

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-CEFPROZIL Discontinued 2019-06-12 2019-06-12 86542
APO-CEFPROZIL Discontinued 2019-05-17 2019-05-18 84396
APO-AMOXI CLAV Discontinued 2019-05-17 2019-05-18 84392
APO-AMOXI CLAV 250MG/62.5MG PER 5ML Discontinued 2019-05-13 2019-05-13 83981
APO-ALMOTRIPTAN Discontinued 2019-05-13 2019-05-13 83976
APO-ALMOTRIPTAN Discontinued 2019-05-13 2019-05-13 83971
APO-SOLIFENACIN 5MG TABLET Discontinued 2019-03-11 2019-09-20 78272
APO-SOLIFENACIN 10MG TABLET Discontinued 2019-03-11 2019-09-20 78269
APO-RISPERIDONE 1MG SOLUTION To be discontinued 2019-03-11 2019-03-11 78260
APO-NEVIRAPINE XR 400MG TABLET (EXTENDED-RELEASE) Discontinued 2019-03-11 2019-03-11 78257
APO PEN VK Discontinued 2019-03-08 2019-03-08 78144
APO PEN VK Discontinued 2019-03-08 2019-03-08 78141
APO-LOSARTAN 25MG TABLET Discontinued 2019-02-01 2019-02-02 74376
APO-DILTIAZ CD 300MG CAPSULE (CONTROLLED-DELIVERY) Discontinued 2019-02-01 2019-02-02 74366
IBUPROFEN CAPLETS 400MG TABLET Discontinued 2019-01-07 2019-07-13 71451
IBUPROFEN 200MG TABLET Discontinued 2019-01-07 2019-07-22 71439
IBUPROFEN 200MG TABLET Discontinued 2019-01-07 2019-01-07 71436
APO-AMITRIPTYLINE 50MG TABLET To be discontinued 2019-01-04 2021-06-05 71354
APO-AMITRIPTYLINE 25MG TABLET Discontinued 2019-01-04 2019-02-13 71351
APO-AMITRIPTYLINE 10MG TABLET Discontinued 2019-01-04 2019-01-04 71348

Showing 41 to 60 of 356